Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 2 hours 34 min ago

SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Singular Genomics Systems, Inc. (NasdaqCM: OMIC) to an affiliate of Deerfield Management Company, L.P. Under the terms of the proposed transaction, shareholders of Singular will receive $20.00 in cash for each share of Singular that they own. KSF is seeking to determine whether this consideration and the proce

NORDSTROM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nordstrom, Inc. - JWN

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Nordstrom, Inc. (NYSE: JWN) to Erik, Pete, Jamie Nordstrom and other members of the Nordstrom family (collectively, the “Nordstrom Family”) and El Puerto de Liverpool, S.A.B. de C.V. Under the terms of the proposed transaction, shareholders of Nordstrom will receive $24.25 in cash for each share of Nordstrom t

MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marinus Pharmaceuticals, Inc. (NasdaqGM: MRNS) to Immedica Pharma AB. Under the terms of the proposed transaction, shareholders of Marinus will receive $0.55 in cash for each share of Marinus that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or w

MAIDEN HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Maiden Holdings, Ltd. - MHLD

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Maiden Holdings, Ltd. (NasdaqCM: MHLD) and Kestrel Group LLC. Pursuant to the terms of the agreement, at the closing of the transaction, each issued and outstanding common share of Maiden will be converted into the right to receive one common share in a newly formed Bermuda company that will acquire both Mai

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Revance Therapeutics, Inc. (RVNC) Investors To Inquire About Securities Fraud Class Action

Mon, 01/06/2025 - 18:43
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) securities between February 29, 2024 and December 6, 2024, inclusive (the “Class Period”). Revance investors have until March 4, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOS

NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeueHealth, Inc. (NYSE: NEUE) to an affiliate of New Enterprise Associates. Under the terms of the proposed transaction, shareholders of NeueHealth will receive $7.33 in cash for each share of NeueHealth that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad

VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Vincerx Pharma, Inc. (NasdaqCM: VINC) and Oqory, Inc. Pursuant to the terms of the agreement, at the closing of the transaction, Vincerx equity holders will hold about 5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger

VACASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vacasa, Inc. - VCSA

Mon, 01/06/2025 - 18:43
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Vacasa, Inc. (NasdaqGS: VCSA) to Casago. Under the terms of the proposed transaction, shareholders of Vacasa will receive $5.02 in cash for each share of Vacasa that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration underv

Northern Trust Corporation to Webcast Fourth Quarter 2024 Earnings Conference Call

Mon, 01/06/2025 - 18:43
CHICAGO--(BUSINESS WIRE)--Northern Trust Corporation announced today that it will webcast its fourth quarter 2024 earnings conference call live on Thursday, January 23, 2025. The webcast, the earnings press release, and related presentation materials will be accessible on Northern Trust’s website. The call will be conducted at 8:00 a.m. (CT), following the release that morning of Northern Trust’s fourth quarter 2024 earnings press release. A replay of the webcast will be available for approxima

Sixth Street Lending Partners Prices Offering of $750.0 million 6.125% Notes due 2030

Mon, 01/06/2025 - 18:43
NEW YORK--(BUSINESS WIRE)--Sixth Street Lending Partners (“SSLP” or the “Company”) announced today that it has priced an offering of $750.0 million in aggregate principal amount of 6.125% notes due 2030 (the “Notes”). The Notes will mature on July 15, 2030, and may be redeemed in whole or in part at SSLP’s option at any time at par plus a “make-whole” premium, if applicable. The offering is subject to customary closing conditions and is expected to close on or about January 13, 2025. SSLP expec

Bank of Hawai‘i Corporation Conference Call to Discuss Fourth Quarter 2024 Financial Results and Board Declares Quarterly Preferred Stock Dividends

Mon, 01/06/2025 - 18:43
HONOLULU--(BUSINESS WIRE)--Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) will release fourth quarter 2024 financial results on Monday, January 27, 2025 before the market opens and hold its quarterly conference call at 1:00 p.m. Eastern Time (8:00 a.m. Hawai‘i Time) on the same day. The live call, including a slide presentation, will be accessible on the investor relations link of Bank of Hawai‘i Corporation's website, www.boh.com. The webcast link is https://register-conf.media-server

Shareholder Alert: Ademi LLP investigates whether Inari Medical, Inc. is obtaining a Fair Price for its Public Shareholders

Mon, 01/06/2025 - 18:43
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Inari (NASDAQ: NARI) for possible breaches of fiduciary duty and other violations of law in its transaction with the Stryker. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Inari stockholders will receive $80 per share, representing a total fully diluted equity value of approximatel

SmartFinancial Sets Dates for Fourth Quarter Earnings Release and Conference Call

Mon, 01/06/2025 - 18:43
KNOXVILLE, Tenn.--(BUSINESS WIRE)--SmartFinancial, Inc. ("SmartFinancial") (NYSE: SMBK) announces details for the release of its results for the Fourth Quarter of 2024. SmartFinancial plans to issue its earnings release for the fourth quarter of 2024 on Tuesday, January 21, 2025, after market close, and will host a conference call on Wednesday, January 22, 2025, at 10:00 a.m. ET. To access this interactive teleconference, dial (833) 470-1428 or (404) 975-4839 and enter the access code, 994691.

CCC Intelligent Solutions Completes Acquisition of EvolutionIQ

Mon, 01/06/2025 - 18:43
CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Inc. (“CCC”), a leading cloud platform provider powering the P&C insurance economy and a subsidiary of CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCCS) (“CCCS”), announced today that it has completed the previously announced acquisition of EvolutionIQ, Inc. (“EvolutionIQ”), the leading platform for AI-powered guidance for disability and injury claims management. “We are excited to officially welcome the EvolutionIQ team to the CCC fa

Amerant Bancorp Inc. to Announce Fourth Quarter 2024 Financial Results and Host Conference Call

Mon, 01/06/2025 - 18:43
CORAL GABLES, Fla.--(BUSINESS WIRE)--Amerant Bancorp Inc. (NYSE: AMTB) (“Amerant” or the “Company”), today announced it will release fourth quarter 2024 earnings results on Wednesday, January 22, 2025 after the market closes. Once released, investors may access Amerant’s earnings results at https://investor.amerantbank.com by choosing “Financial Results” under the “Financials Info” heading. On Thursday, January 23, 2025, Jerry Plush, Chairman and Chief Executive Officer, and Sharymar Calderón,

Law Offices of Howard G. Smith Encourages Revance Therapeutics, Inc. (RVNC) Investors To Inquire About Securities Fraud Class Action

Mon, 01/06/2025 - 18:43
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) securities between February 29, 2024 and December 6, 2024, inclusive (the “Class Period”). Revance investors have until March 4, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN REVANCE THERAPEUTICS, INC. (RVNC), CONTACT THE LAW OFFICES OF

Air Lease Corporation Announces Fourth Quarter and Year End 2024 Earnings Conference Call

Mon, 01/06/2025 - 18:43
LOS ANGELES--(BUSINESS WIRE)--Air Lease Corporation (NYSE: AL) will host a conference call on February 13, 2025 at 4:30 PM Eastern Time to discuss the Company's financial results for the fourth quarter and year end 2024. Investors can participate in the conference call by dialing 1 (800) 715-9871 domestic or 1 (646) 307-1963 international. The passcode for the call is 7572001. The conference call will also be broadcast live through a link on the Investors page of the Air Lease Corporation websi

Enterprise Financial Services Corp Announces Fourth Quarter 2024 Earnings Release and Conference Call

Mon, 01/06/2025 - 18:43
ST. LOUIS--(BUSINESS WIRE)--Enterprise Financial Services Corp (Nasdaq: EFSC) (“the Company” or “EFSC”) will release its fourth quarter 2024 financial results on Monday, January 27, 2025. The Company will host a conference call and webcast at 10:00 a.m. CT on Tuesday, January 28, 2025. Participate by Dial-In We encourage participants to pre-register for the conference call using the following link: https://bit.ly/EFSC4Q2024EarningsCallRegistration. Callers who pre-register will be given a confe

Golub Capital BDC, Inc. Schedules Release of Fiscal Year 2025 First Quarter Results

Mon, 01/06/2025 - 18:43
NEW YORK--(BUSINESS WIRE)--Golub Capital BDC, Inc., a business development company (NASDAQ: GBDC, www.golubcapitalbdc.com), announced today that it will report its financial results for the quarter ended December 31, 2024 on Tuesday, February 4, 2025 after the close of the financial markets. Golub Capital BDC, Inc. will host an earnings conference call at 10:00 a.m. (Eastern Time) on Wednesday, February 5, 2025 to discuss its quarterly financial results. All interested parties may participate i

Independent Bank Corp.’s Announcement of Date of Fourth Quarter Conference Call

Mon, 01/06/2025 - 18:43
ROCKLAND, Mass.--(BUSINESS WIRE)--Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, will host its quarterly conference call to discuss fourth quarter results on Friday, January 17, 2025, at 10:00 AM Eastern Time. Telephonic access will be available by dial-in at 888-336-7153 reference: INDB. Participants may also choose to pre-register for the conference by navigating to https://dpregister.com/sreg/10194177/fde0484bd2 which will provide a unique PIN t

Pages